The University of Chicago Header Logo

Connection

David Grdina to Female

This is a "connection" page, showing publications David Grdina has written about Female.
Connection Strength

0.256
  1. Altered expression of a metformin-mediated radiation response in SA-NH and FSa tumor cells treated under in vitro and in vivo growth conditions. Int J Radiat Biol. 2017 07; 93(7):665-675.
    View in: PubMed
    Score: 0.029
  2. Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity. Free Radic Biol Med. 2016 10; 99:110-119.
    View in: PubMed
    Score: 0.028
  3. A survivin-associated adaptive response in radiation therapy. Cancer Res. 2013 Jul 15; 73(14):4418-28.
    View in: PubMed
    Score: 0.022
  4. A manganese superoxide dismutase (SOD2)-mediated adaptive response. Radiat Res. 2013 Feb; 179(2):115-24.
    View in: PubMed
    Score: 0.022
  5. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):886-96.
    View in: PubMed
    Score: 0.017
  6. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591.
    View in: PubMed
    Score: 0.009
  7. Amifostine: mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact. 2000; 16(4):237-79.
    View in: PubMed
    Score: 0.009
  8. Protection from radiation-induced apoptosis by the radioprotector amifostine (WR-2721) is radiation dose dependent. Cell Biol Toxicol. 2014 Feb; 30(1):55-66.
    View in: PubMed
    Score: 0.006
  9. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013 Dec; 45(12):1439-45.
    View in: PubMed
    Score: 0.006
  10. The effects of radiation and dose-fractionation on cancer and non-tumor disease development. Int J Environ Res Public Health. 2012 Dec 18; 9(12):4688-703.
    View in: PubMed
    Score: 0.005
  11. CyclinB1/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress. J Mol Cell Biol. 2013 Jun; 5(3):166-75.
    View in: PubMed
    Score: 0.005
  12. In vivo protection by the aminothiol WR-2721 against neutron-induced carcinogenesis. Int J Radiat Biol. 1992 May; 61(5):567-76.
    View in: PubMed
    Score: 0.005
  13. Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry. Gynecol Oncol. 1992 Jan; 44(1):10-2.
    View in: PubMed
    Score: 0.005
  14. Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons. Adv Space Res. 1992; 12(2-3):257-63.
    View in: PubMed
    Score: 0.005
  15. Protection by WR-151327 against late-effect damage from fission-spectrum neutrons. Radiat Res. 1991 Oct; 128(1 Suppl):S124-7.
    View in: PubMed
    Score: 0.005
  16. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1991 Aug 15; 51(16):4125-30.
    View in: PubMed
    Score: 0.005
  17. Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma. Clin Exp Metastasis. 1989 Mar-Apr; 7(2):243-50.
    View in: PubMed
    Score: 0.004
  18. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine. Int J Radiat Biol. 2008 Aug; 84(8):623-34.
    View in: PubMed
    Score: 0.004
  19. Protective effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation within one day after birth. Cancer Res. 1985 Nov; 45(11 Pt 1):5379-81.
    View in: PubMed
    Score: 0.003
  20. Effectiveness of AMSA alone or in combination with radiation on murine fibrosarcoma pulmonary nodules. Clin Exp Metastasis. 1984 Jul-Sep; 2(3):223-33.
    View in: PubMed
    Score: 0.003
  21. Cell synchrony techniques. I. A comparison of methods. Cell Tissue Kinet. 1984 May; 17(3):223-36.
    View in: PubMed
    Score: 0.003
  22. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range. Int J Radiat Oncol Biol Phys. 1984 Mar; 10(3):379-83.
    View in: PubMed
    Score: 0.003
  23. Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules. Br J Cancer. 1983 Aug; 48(2):279-87.
    View in: PubMed
    Score: 0.003
  24. Oral administration is as effective as intraperitoneal administration of amifostine in decreasing nitroxide EPR signal decay in vivo. Biochim Biophys Acta. 2003 Mar 20; 1637(2):151-5.
    View in: PubMed
    Score: 0.003
  25. Treatment of artificially-induced pulmonary metastases with fractionated doses of vincristine and/or radiation therapy. Clin Exp Metastasis. 1983 Jan-Mar; 1(1):71-81.
    View in: PubMed
    Score: 0.003
  26. Cyclic-radiation response of murine fibrosarcoma cells grown as pulmonary nodules. Int J Radiat Oncol Biol Phys. 1982 Oct; 8(10):1727-34.
    View in: PubMed
    Score: 0.003
  27. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma pulmonary nodules. Br J Cancer. 1982 Mar; 45(3):438-46.
    View in: PubMed
    Score: 0.003
  28. Density centrifugation of murine fibrosarcoma cells following in situ labelling with tritiated thymidine. Cell Tissue Kinet. 1981 Nov; 14(6):589-600.
    View in: PubMed
    Score: 0.003
  29. Cytotoxic effect in vivo of selected chemotherapeutic agents on synchronized murine fibrosarcoma cells. Br J Cancer. 1980 Nov; 42(5):677-83.
    View in: PubMed
    Score: 0.002
  30. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations. Cancer Clin Trials. 1980; 3(2):149-54.
    View in: PubMed
    Score: 0.002
  31. Cytotoxic effect of adriamycin in vivo on synchronized murine fibrosarcoma cells. Int J Radiat Oncol Biol Phys. 1979 Aug; 5(8):1305-8.
    View in: PubMed
    Score: 0.002
  32. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma cells synchronized by centrifugal elutriation. Br J Cancer. 1979 Feb; 39(2):152-8.
    View in: PubMed
    Score: 0.002
  33. Separation of cells from a murine fibrosarcoma on the basis of size. I. Relationship between cell size and age as modified by growth in vivo or in vitro. J Natl Cancer Inst. 1978 Jul; 61(1):209-14.
    View in: PubMed
    Score: 0.002
  34. Separation of cells from a murine fibrosarcoma on the basis of size. II. Differential effects of cell size and age on lung retention and colony formation in normal and preconditioned mice. J Natl Cancer Inst. 1978 Jul; 61(1):215-20.
    View in: PubMed
    Score: 0.002
  35. Regulation of thymus PCNA expression is altered in radiation-sensitive wasted mice. Carcinogenesis. 1996 Nov; 17(11):2357-65.
    View in: PubMed
    Score: 0.002
  36. Radiation response of cell populations irradiated in situ and separated from a fibrosarcoma. Radiat Res. 1976 Jun; 66(3):634-43.
    View in: PubMed
    Score: 0.002
  37. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res. 1996 May; 145(5):610-8.
    View in: PubMed
    Score: 0.002
  38. Separation of clonogenic cells from stationary phase cultures and a murine fibrosarcoma by density-gradient centrifugation. Methods Cell Biol. 1976; 14:213-28.
    View in: PubMed
    Score: 0.002
  39. Radiation response of clonogenic cell populations separated from fibrosarcoma. Radiat Res. 1975 Sep; 63(3):483-93.
    View in: PubMed
    Score: 0.002
  40. Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation. Int J Radiat Oncol Biol Phys. 1994 Nov 15; 30(4):867-72.
    View in: PubMed
    Score: 0.002
  41. Separation of clonogenic cells from stationary phase cultures by density gradient centrifugation. Exp Cell Res. 1974 Mar 30; 85(1):15-22.
    View in: PubMed
    Score: 0.001
  42. Separation of cells from a fibrosarcoma in renografin density gradients. J Natl Cancer Inst. 1974 Jan; 52(1):253-7.
    View in: PubMed
    Score: 0.001
  43. Buoyant density separation of human blood cells in renografin gradients. Exp Cell Res. 1973 Sep; 81(1):250-4.
    View in: PubMed
    Score: 0.001
  44. The inherent cellular radiosensitivity of epithelial ovarian carcinoma. Gynecol Oncol. 1989 Dec; 35(3):282-5.
    View in: PubMed
    Score: 0.001
  45. Characterization of a human ovarian carcinoma. Anal Quant Cytol Histol. 1989 Oct; 11(5):324-30.
    View in: PubMed
    Score: 0.001
  46. The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma. Am J Obstet Gynecol. 1989 Apr; 160(4):789-97.
    View in: PubMed
    Score: 0.001
  47. The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy. Gynecol Oncol. 1989 Feb; 32(2):236-9.
    View in: PubMed
    Score: 0.001
  48. Effects of separate and combined treatments with gamma radiation and diethylnitrosamine in neonatal rats on the induction of altered hepatocyte foci and hepatic tumors. Carcinogenesis. 1987 Apr; 8(4):599-600.
    View in: PubMed
    Score: 0.001
  49. Synergistic induction of altered hepatocyte foci by combined gamma radiation and diethylnitrosamine administered to neonatal rats. Carcinogenesis. 1986 Mar; 7(3):445-8.
    View in: PubMed
    Score: 0.001
  50. Cell synchrony techniques. II. Analysis of cell progression data. Cell Tissue Kinet. 1984 May; 17(3):237-45.
    View in: PubMed
    Score: 0.001
  51. Separation of cells from mouse solid tumors by centrifugal elutriation. Cancer Res. 1977 Dec; 37(12):4291-6.
    View in: PubMed
    Score: 0.000
  52. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum. J Natl Cancer Inst. 1975 Apr; 54(4):895-902.
    View in: PubMed
    Score: 0.000
  53. Destruction of hamster ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst. 1974 Jun; 52(6):1839-42.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.